NYSE: ORAOrmat Technologies Inc Stock
$62.92+0.81 (+1.3%)
Updated Apr 18, 2024
ORA Price
$62.92
Fair Value Price
N/A
Market Cap
$3.80B
52 Week Low
$58.73
52 Week High
$88.64
P/E
30.11x
P/B
1.64x
P/S
5.43x
PEG
3.38x
Dividend Yield
0.76%
Revenue
$829.42M
Earnings
$124.40M
Gross Margin
31.8%
Operating Margin
27.64%
Profit Margin
15%
Debt to Equity
1.19
Operating Cash Flow
$309M
Beta
0.86
Next Earnings
May 7, 2024
Ex-Dividend
N/A
Next Dividend
N/A
ORA Overview
Ormat Technologies, Inc. sells, owns, and operates geothermal and recovered energy-based power plants. The company also manufactures products that produce electricity from recovered energy or waste heat. Nearly two thirds of its capacity is in the U.S. with the balance in Africa and Central America. Ormat Technologies was founded in 1965 and is based in Reno, NV.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ORA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ORA ($62.92) is trading above its intrinsic value of $17.99, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ORA is good value based on its earnings relative to its share price (30.11x), compared to the US market average (41.33x)
P/E vs Market Valuation
ORA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more ORA due diligence checks available for Premium users.
Be the first to know about important ORA news, forecast changes, insider trades & much more!
ORA News
Valuation
ORA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
30.11x
Industry
30.85x
Market
41.33x
ORA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ORA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ORA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.64x
Industry
2.52x
ORA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ORA price to earnings growth (PEG)
For valuing profitable companies with growth potential
ORA is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
ORA's financial health
Profit margin
Revenue
$241.3M
Net Income
$35.7M
Profit Margin
14.8%
ORA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ORA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.2B
Liabilities
$2.8B
Debt to equity
1.19
ORA's short-term assets ($646.00M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ORA's long-term liabilities ($2.22B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ORA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ORA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$139.1M
Investing
-$170.2M
Financing
$132.4M
ORA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ORA vs Renewable Energy Stocks
Ormat Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.